18F-P137

N/A

Report date: 2025/09/24 16:11:35

NME

Base Information

Drug Name18F-P137

Drug Alias Name18F-P137

ClassificationRadiation-emitting products > Nuclides > Fluorine > 18FRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionProstate-Specific Membrane Antigen modulators

TargetsProstate-Specific Membrane Antigen

Therapy Area/IndicationsNasopharyngeal CarcinomaNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesThe First Affiliated Hospital Of Beijing University

China Registration ClassN/A

Develop Information

Active CompaniesHainan Provincial People'S Hospital

Inactive CompaniesThe First Affiliated Hospital Of Beijing University

Active IndicationsNasopharyngeal Carcinoma

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A